News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Cardiac Dimensions, Inc. Announces New Vice President of Research & Development
November 18, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions® Inc., is pleased to announce that Mr. Robert Conta has joined the company as Vice President of Research and Development (R&D).
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Business
Novo hit with cybersecurity breach, urges vigilance among trial participants
June 12, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
June 11, 2026
·
1 min read
·
Angela Gabriel
IPO tracker
Kardigan stitches up $369M IPO plan
June 11, 2026
·
16 min read
·
Editorial Team
Funding
SonoThera bags $125M series B to advance safer gene therapies
June 11, 2026
·
2 min read
·
Tristan Manalac